A subset analysis of a phase II trial evaluating the use of DFMO as maintenance therapy for high‐risk neuroblastoma - Lewis, Elizabeth C.; Kraveka, Jacqueline M.; Ferguson, William; Eslin, Don; Brown, Valerie I.; Bergendahl, Genevieve; Roberts, William; Wada, Randal K.; Oesterheld, Javier; Mitchell, Deanna; Foley, Jessica; Zage, Peter; et al. (International journal of cancer, 2020)
Keywords: Cancer; Cancer Therapy and Prevention; Child, Preschool; Children; DFMO; Disease-Free Survival; Eflornithine - administration & dosage; Eflornithine - therapeutic use; Female; high‐risk neuroblastoma; Humans; Immunotherapy; maintenance; Maintenance Chemotherapy; Male; Medical prognosis; Medical research; Neuroblastoma; Neuroblastoma - drug therapy; Prognosis; Short Report; Standard of Care; Survival; Sympathetic nervous system; Treatment Outcome; maintenance; high-risk neuroblastoma; DFMO